GlassScriptPhysician profile
Samuel William Streit
NPI 1952467672
$13,456.26
in general payments reported to CMS, 2019-2025
46 companies · $2,042 in 2025
The $2,042 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,842 · 2020: $916 · 2021: $1,392 · 2022: $1,808 · 2023: $2,546 · 2024: $2,911 · 2025: $2,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,498.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,969.41 | 2019-2025 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $1,465.49 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $1,455.01 | 2019-2025 | Farxiga, Breztri, Flumist Quadrivalent |
| Abbvie INC. | $1,370.86 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Novo Nordisk INC | $1,292.02 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,030.73 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $735.41 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $581.46 | 2019-2025 | Gardasil 9, Gardasil, Capvaxive |
| Amgen INC. | $571.20 | 2019-2025 | Evenity, Prolia, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $320.77 | 2021-2025 | |
| Exact Sciences Corporation | $317.66 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $299.59 | 2023-2025 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $281.30 | 2022-2025 | Xifaxan |
| Amarin Pharma, INC. | $203.16 | 2019-2022 | |
| Abbott Laboratories | $195.88 | 2022-2025 | Freestyle Libre 3 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Streit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.